The complex association between COPD and COVID-19

NT Awatade, PAB Wark, ASL Chan… - Journal of Clinical …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is significant cause of morbidity and
mortality worldwide. There is mounting evidence suggesting that COPD patients are at …

Two in one: Overlapping CT findings of COVID-19 and underlying lung diseases

G Durhan, SA Düzgün, Y Baytar, MG Akpınar… - Clinical Imaging, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is associated with pneumonia and has
various pulmonary manifestations on computed tomography (CT). Although COVID-19 …

Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19

CY Hu, WS Cui, Y Lei, YW Tang, YY Zhang… - Infection and Drug …, 2023 - Taylor & Francis
Purpose To compare the effectiveness of azvudine and nirmatrelvir/ritonavir for the treatment
of coronavirus disease (COVID-19). Patients and Methods We conducted a retrospective …

[HTML][HTML] Outcomes of patients with COPD hospitalized for coronavirus disease 2019

DAP Neira, A Watts, J Seashore, A Duarte… - … Diseases: Journal of …, 2021 - ncbi.nlm.nih.gov
Rationale: There is controversy concerning the association of chronic obstructive pulmonary
disease (COPD) as an independent risk factor for mortality in patients hospitalized with …

Explainable emphysema detection on chest radiographs with deep learning

E Çallı, K Murphy, ET Scholten, S Schalekamp… - Plos one, 2022 - journals.plos.org
We propose a deep learning system to automatically detect four explainable emphysema
signs on frontal and lateral chest radiographs. Frontal and lateral chest radiographs from …

[HTML][HTML] Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease

LC Myers, R Murray, B Donato, VX Liu, P Kipnis… - Respiratory …, 2023 - Elsevier
Background and objective Patients with chronic obstructive pulmonary disease (COPD) may
have worse coronavirus disease-2019 (COVID-19)–related outcomes. We compared COVID …

Respiratory Interventions, Hospital Utilization, and Clinical Outcomes of Persons with COPD and COVID-19

AA Elshafei, SA Flores, R Kaur… - International journal of …, 2023 - Taylor & Francis
Purpose Coronavirus disease 2019 (COVID-19) impacted outcomes of persons with chronic
respiratory diseases such as chronic obstructive pulmonary disease (COPD). This study …

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity

M Jaberi-Douraki, E Meyer, J Riviere, NIM Gedara… - Scientific reports, 2021 - nature.com
Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive
medications with outcomes in patients with hypertension is not fully described. However …

Pre-and post-vaccination characteristics and risk factors for COVID-19 outcomes in a Swedish population-based cohort of COPD patients

BK Kirui, A Santosa, LEGW Vanfleteren, H Li… - ERJ Open …, 2023 - Eur Respiratory Soc
Rationale Evidence on risk factors for Coronavirus disease 2019 (COVID-19) outcomes
among patients with COPD in relation to COVID-19 vaccination remains limited. The …

[PDF][PDF] The impact of covid-19 on coronary heart failure patients and co-morbid diseases

A Bener, A Naser, CC Barışık, M Atmaca… - … Journal of Advanced …, 2022 - comedjournal.com
Objective: The objective of this study was to evaluate the risk of serious adverse outcomes in
patients with Chronic Coronary Heart Failure (CHF) related COVID-19 by stratifying the co …